Annual CFI
-$28.61 M
-$134.38 M-127.04%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual cash flow from investing activities is -$28.61 million, with the most recent change of -$134.38 million (-127.04%) on December 31, 2023.
- During the last 3 years, MRNS annual CFI has fallen by -$27.87 million (-3776.02%).
- MRNS annual CFI is now -127.04% below its all-time high of $105.77 million, reached on December 31, 2022.
Performance
MRNS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$1.11 M
-$10.08 M-112.43%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly cash flow from investing activities is -$1.11 million, with the most recent change of -$10.08 million (-112.43%) on September 30, 2024.
- Over the past year, MRNS quarterly CFI has stayed the same.
- MRNS quarterly CFI is now -101.05% below its all-time high of $106.11 million, reached on September 30, 2022.
Performance
MRNS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$35.20 M
-$13.03 M-27.02%
September 30, 2024
Summary
- As of February 8, 2025, MRNS TTM cash flow from investing activities is $35.20 million, with the most recent change of -$13.03 million (-27.02%) on September 30, 2024.
- Over the past year, MRNS TTM CFI has stayed the same.
- MRNS TTM CFI is now -66.72% below its all-time high of $105.77 million, reached on December 31, 2022.
Performance
MRNS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MRNS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -127.0% | 0.0% | 0.0% |
| 3 y3 years | -3776.0% | -1510.1% | -66.7% |
| 5 y5 years | -243.6% | -1510.1% | -66.7% |
MRNS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -127.0% | at low | -101.0% | +97.9% | -66.7% | +200.6% |
| 5 y | 5-year | -127.0% | at low | -101.0% | +97.9% | -66.7% | +200.6% |
| alltime | all time | -127.0% | at low | -101.0% | +97.9% | -66.7% | +200.6% |
Marinus Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.11 M(-112.4%) | $35.20 M(-27.0%) |
| Jun 2024 | - | $8.96 M(-57.1%) | $48.23 M(+8.9%) |
| Mar 2024 | - | $20.89 M(+223.0%) | $44.27 M(-254.8%) |
| Dec 2023 | -$28.61 M(-127.0%) | $6.47 M(-45.8%) | -$28.61 M(-18.3%) |
| Sep 2023 | - | $11.92 M(+138.2%) | -$34.99 M(-159.1%) |
| Jun 2023 | - | $5.00 M(-109.6%) | $59.20 M(+9.9%) |
| Mar 2023 | - | -$51.99 M(<-9900.0%) | $53.86 M(-49.1%) |
| Dec 2022 | $105.77 M(-7575.1%) | $79.00 K(-99.9%) | $105.77 M(+0.8%) |
| Sep 2022 | - | $106.11 M(<-9900.0%) | $104.97 M(-5312.1%) |
| Jun 2022 | - | -$335.00 K(+289.5%) | -$2.01 M(-20.8%) |
| Mar 2022 | - | -$86.00 K(-88.1%) | -$2.54 M(+79.7%) |
| Dec 2021 | -$1.42 M(+91.7%) | -$721.00 K(-17.3%) | -$1.42 M(-179.1%) |
| Sep 2021 | - | -$872.00 K(+0.9%) | $1.79 M(-68.3%) |
| Jun 2021 | - | -$864.00 K(-182.9%) | $5.64 M(-19.4%) |
| Mar 2021 | - | $1.04 M(-58.0%) | $7.00 M(-1048.6%) |
| Dec 2020 | -$738.00 K(-119.0%) | $2.48 M(-16.8%) | -$738.00 K(-41.2%) |
| Sep 2020 | - | $2.98 M(+502.4%) | -$1.26 M(-72.0%) |
| Jun 2020 | - | $495.00 K(-107.4%) | -$4.49 M(-41.5%) |
| Mar 2020 | - | -$6.70 M(-441.0%) | -$7.68 M(-298.0%) |
| Dec 2019 | $3.88 M | $1.96 M(-870.2%) | $3.88 M(-77.0%) |
| Sep 2019 | - | -$255.00 K(-90.5%) | $16.84 M(-23.8%) |
| Jun 2019 | - | -$2.70 M(-155.4%) | $22.10 M(-10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $4.87 M(-67.4%) | $24.79 M(+24.5%) |
| Dec 2018 | $19.92 M(-193.0%) | $14.92 M(+198.3%) | $19.92 M(+280.7%) |
| Sep 2018 | - | $5.00 M(>+9900.0%) | $5.23 M(-121.4%) |
| Jun 2018 | - | $0.00(-100.0%) | -$24.46 M(+6.2%) |
| Mar 2018 | - | -$8000.00(-103.4%) | -$23.04 M(+7.6%) |
| Dec 2017 | -$21.42 M(-1634.4%) | $238.00 K(-101.0%) | -$21.42 M(+0.0%) |
| Sep 2017 | - | -$24.69 M(-1835.3%) | -$21.41 M(-572.0%) |
| Jun 2017 | - | $1.42 M(-11.7%) | $4.54 M(+149.5%) |
| Mar 2017 | - | $1.61 M(+550.0%) | $1.82 M(+30.2%) |
| Dec 2016 | $1.40 M(-122.1%) | $248.00 K(-80.2%) | $1.40 M(-15.3%) |
| Sep 2016 | - | $1.25 M(-196.8%) | $1.65 M(-136.0%) |
| Jun 2016 | - | -$1.29 M(-208.8%) | -$4.58 M(+26.0%) |
| Mar 2016 | - | $1.19 M(+137.5%) | -$3.63 M(-42.5%) |
| Dec 2015 | -$6.31 M(>+9900.0%) | $501.00 K(-110.1%) | -$6.31 M(-7.4%) |
| Sep 2015 | - | -$4.97 M(+1312.5%) | -$6.82 M(+269.8%) |
| Jun 2015 | - | -$352.00 K(-76.4%) | -$1.84 M(+23.6%) |
| Mar 2015 | - | -$1.49 M(>+9900.0%) | -$1.49 M(+8670.6%) |
| Dec 2014 | -$33.00 K(+94.1%) | - | - |
| Dec 2013 | -$17.00 K(+209.1%) | -$3000.00(+50.0%) | -$17.00 K(+21.4%) |
| Sep 2013 | - | -$2000.00(-75.0%) | -$14.00 K(+16.7%) |
| Jun 2013 | - | -$8000.00(+100.0%) | -$12.00 K(+200.0%) |
| Mar 2013 | - | -$4000.00 | -$4000.00 |
| Dec 2012 | -$5500.00 | - | - |
FAQ
- What is Marinus Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual CFI year-on-year change?
- What is Marinus Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly CFI year-on-year change?
- What is Marinus Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals TTM CFI year-on-year change?
What is Marinus Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of MRNS is -$28.61 M
What is the all time high annual CFI for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual cash flow from investing activities is $105.77 M
What is Marinus Pharmaceuticals annual CFI year-on-year change?
Over the past year, MRNS annual cash flow from investing activities has changed by -$134.38 M (-127.04%)
What is Marinus Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of MRNS is -$1.11 M
What is the all time high quarterly CFI for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly cash flow from investing activities is $106.11 M
What is Marinus Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, MRNS quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Marinus Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of MRNS is $35.20 M
What is the all time high TTM CFI for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high TTM cash flow from investing activities is $105.77 M
What is Marinus Pharmaceuticals TTM CFI year-on-year change?
Over the past year, MRNS TTM cash flow from investing activities has changed by $0.00 (0.00%)